Englewood Lab, Inc. (KOSDAQ:950140)

Market Cap	204.64B
Revenue (ttm)	204.62B
Net Income (ttm)	25.12B
Shares Out	19.87M
EPS (ttm)	1,263.90
PE Ratio	8.15
Forward PE	10.06
Dividend	100.00 (0.94%)
Ex-Dividend Date	Dec 27, 2024

Volume	44,068
Average Volume	84,225
Open	10,700
Previous Close	10,700
Day's Range	10,570 - 10,800
52-Week Range	6,650 - 16,910
Beta	0.47
RSI	28.52
Earnings Date	Feb 23, 2026

About Englewood Lab

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2004
• Country: United States
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950140

Financial Performance

In 2024, Englewood Lab's revenue was 182.22 billion, a decrease of -11.88% compared to the previous year's 206.78 billion. Earnings were 19.63 billion, a decrease of -5.37%.